Pfizer and Moderna raise the price of their anticovid vaccines. The US pharmaceutical companies Pfizer and Moderna raised the price of their anticovid vaccines by more than a quarter and a tenth, respectively, in the last supply contracts to the European Union, affirms this Sunday the newspaper “Financial Times”.
The terms of the contracts, signed this year through 2023 for a total of 2.1 billion doses, were renegotiated after clinical studies indicated that mRNA vaccines from these two companies had better efficacy rates than the cheaper ones from Oxford / AstraZeneca and Johnson & Johnson, says the newspaper.
Pfizer and Moderna raise the price of their anticovid vaccines
The price of a dose of the Pfizer preparation went from the current 15.50 euros to 19.50 euros, according to parts of the contract to which the FT has had access.
The price of a dose of Moderna rose to $ 25.50, from about 19 euros or $ 22.60 set in first supply agreement.
Nevertheless, That amount is less than the $ 28.5 that had been previously agreed, because the order was increased, explains the newspaper.
The newspaper notes that drug companies will make a lot of money as countries increase their orders to administer third doses of the vaccine next winter.
According to data from industry consultants, in 2022 it is expected that Pfizer, that shares profits with the German BioNTech, earns 56,000 million dollars from the sale of its vaccine, while Moderna would earn about 30,000 million.
AstraZeneca, which offers its preparation at cost price indefinitely to developing countries, would earn about $ 15 billion, says the FT.
According to the newspaper, the EU negotiated the most expensive new contracts with Pfizer and Moderna at one point when he was under pressure to increase supply.